#LCSM Transcript
Healthcare social media transcript of the #LCSM hashtag.
– ().
See #LCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Bob Steele @steele_bob I see https://t.co/a2EAq02tQu is not working again. I'm using tweetchat tonight #lcsm |
 | Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Welcome to #LCSM Chat! Our topic for March 7th: Biomarker Magicians, (or Why We Love Pathologists) More info at https://t.co/QszYTpYn3I |
 | #LCSM Chat @lcsmchat RT @TimAllenMDJD: Welcome to #LCSM Chat! Our topic for March 7th: Welcome to #LCSM Chat! Our topic for March 7th: Biomarker Magicians, (or Why We Love Pathologists) More info at https://t.co/QszYTpYn3I |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology at the University of Mississippi Medical Center in Jackson, Mississippi #LCSM |
 | Faces of Lung Cancer @LungCancerFaces RT @TimAllenMDJD: Welcome to #LCSM Chat! Our topic for March 7th: Welcome to #LCSM Chat! Our topic for March 7th: Biomarker Magicians, (or Why We Love Pathologists) More info at https://t.co/QszYTpYn3I |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology at the University of Mississippi Medical Center in Jackson, Mississippi #LCSM |
 | Joni Fowler, PharmD, BCPP @jfowlerpharmd @TimAllenMDJD 👋🏼 Such an important topic! #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We'll get started in a few minutes -- please take a moment to introduce yourselves. #LCSM |
 | Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD Hi Tim! Welcome to your first round of moderating #LCSM Chat! Excited to learn about this topic. #LCSM |
| #LCSM Chat @lcsmchat @jfowlerpharmd @TimAllenMDJD Welcome! #lcsm |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @TimAllenMDJD Hi Tim! Welcome to your first round of moderating #LCSM Chat! Excited to learn about this topic. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We'll get started in a few minutes -- please take a moment to introduce yourselves. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD If you are new to Twitter chats and/or #LCSM Chat, you might find our primer on how to participate helpful https://t.co/shziI4bmml |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thank you, @JFreemanDaily! Looking forward to a great hour with the #LCSM team! |
 | Jill Feldman @jillfeldman4 Hi, Jill here. Looking forward to discussing this important topic! #LCSM |
| Faces of Lung Cancer @LungCancerFaces Deana here coming at you from sunny Los Angeles. I'll be tweeting from the @lcsmchat account tonight. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Please remember to use #LCSM in all your tweets so others participating in the chat can see them. |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD Janet Freeman-Daily -- writer, science geek, stage IV lung cancer patient/activist. https://t.co/OBCc87ZwkG #LCSM |
| #LCSM Chat @lcsmchat @jillfeldman4 Hi Jill! #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Please remember to use #LCSM in all your tweets so others participating in the chat can see them. |
| Janet Freeman-Daily @JFreemanDaily @jillfeldman4 Hi Jill! Good to see you here. #LCSM |
 | KC Dill @kasedill Hello from the Houston suburbs #Lcsm |
| Janet Freeman-Daily @JFreemanDaily @jfowlerpharmd @TimAllenMDJD Hi Joni! Glad you joined us. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Hi, Jill. Welcome! #LCSM |
| KC Dill @kasedill @TimAllenMDJD Hello! #Lcsm |
| #LCSM Chat @lcsmchat @kasedill Welcome! Thanks for joining. #lcsm |
 | Lung Cancer Sux @LungCancerSux Hi there! Hubby is 8+ yr stage IV. Very exciting chat tonight! #LCSM |
| Janet Freeman-Daily @JFreemanDaily @LungCancerFaces @lcsmchat Sunny? We had SNOW again in Seattle. Amazing. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Howdy, @kasedill #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD If you prefer just to listen, please tweet “#LCSM” so we know you’re in the audience (but I urge you ahead and join in! It’s a great #LCSM team!) |
| #LCSM Chat @lcsmchat @LungCancerSux Welcome! Good to "see" you tonight. #lcsm |
 | Upstage Lung Cancer @UpstageLungCanc Hi, friends! Always thrilled to join! We are a performance art-based nonprofit in the Boston area dedicated to raising funds for #lungcancer research! #lcsm |
 | Betsy @MAmaskwearer Hi all. Betsy here. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Please do not promote products or services on the #LCSM feed or during the chat. Feel free to share vetted online resources. |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: If you prefer just to listen, please tweet “#LCSM” so we know you’re in the audience (but I urge you ahead and join in! It’s a great #LCSM team!) |
| Janet Freeman-Daily @JFreemanDaily @kasedill @TimAllenMDJD Welcome KC and LC Sux! @LungCancerSux 8 years surviving LC is terrific. #LCSM |
 | Danielle Pardue @Actorielle Hi, friends! <3 #lcsm |
 | Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat VA Medical oncologist ( here to learn from our pathology team members ) #lcsm |
 | Dianne Grunes @DrGrunes #LCSM First Twitter chat. Happy for it to be on such an important subject. |
| Janet Freeman-Daily @JFreemanDaily @UpstageLungCanc Welcome! When was your most recent performance? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD If you change someone’s words when you retweet, please label it MT (modified tweet). #LCSM |
| Faces of Lung Cancer @LungCancerFaces RT @TimAllenMDJD: If you prefer just to listen, please tweet “#LCSM” so we know you’re in the audience (but I urge you ahead and join in! It’s a great #LCSM team!) |
| Janet Freeman-Daily @JFreemanDaily @wildwestannie Glad you joined us, Betsy. #LCSM |
| KC Dill @kasedill @JFreemanDaily @TimAllenMDJD @LungCancerSux Hi Janet! #Lcsm |
 | H. Jack West, MD @JackWestMD Dr. Jack West here, just having relocated to at least intermittently sunny LA (though recently distressingly rainy & reminiscent of Seattle), & now working at @CityofHope. Very happy to join! #LCSM |
 | Michael Misialek, MD @DrMisialek Hi everyone. Calling all #pathologists to join in the lung cancer chat #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Note: Twitter allows tweets up to 280 characters, but some tweetchat apps (like https://t.co/9aLQyRZrmn) will not display tweets longer than 140. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Please do not promote products or services on the #LCSM feed or during the chat. Feel free to share vetted online resources. |
| #LCSM Chat @lcsmchat @Actorielle Hey lady! #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrGrunes: #LCSM First Twitter chat. Happy for it to be on such an important subject. |
| #LCSM Chat @lcsmchat @DevikaDasMD @TimAllenMDJD Welcome! #lcsm |
| Janet Freeman-Daily @JFreemanDaily @JackWestMD @cityofhope Welcome back, Jack. Sorry Seattle lost you, but glad LA gained some new talent. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD So happy to see familiar Twitter handles as well as new participants tonight! And some new ones! #LCSM |
| Janet Freeman-Daily @JFreemanDaily @DrMisialek Happy to see more #pathology types join the chat! #LCSM |
| Upstage Lung Cancer @UpstageLungCanc @JFreemanDaily October, but our next is coming up in April! https://t.co/mvNhV9II9q. Thank you! #lcsm |
| #LCSM Chat @lcsmchat @DrGrunes Welcome! We are a friendly bunch. #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: If you change someone’s words when you retweet, please label it MT (modified tweet). #LCSM |
| Danielle Pardue @Actorielle RT @DrMisialek: Hi everyone. Calling all #pathologists to join in the lung cancer chat #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Howdy, Jack. #LCSM |
| #LCSM Chat @lcsmchat @JackWestMD @cityofhope It'll get better. Soon you'll be complaining about the heat. Trust me. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Glad you're joining us, Michael. #LCSM |
 | Sarika Jain @drjainsp #LCSM Glad to be on this forum! |
| #LCSM Chat @lcsmchat @DrMisialek Welcome! Glad to have you join us. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD 2d that #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Note: Note: Twitter allows tweets up to 280 characters, but some tweetchat apps (like https://t.co/9aLQyRZrmn) will not display tweets longer than 140. #LCSM |
| Janet Freeman-Daily @JFreemanDaily @drjainsp welcome! #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: So happy to see familiar Twitter handles as well as new participants tonight! And some new ones! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD I will announce FIVE topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #LCSM |
 | Lisa Moran @plh4lisa Sorry i'm late. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We’ll start with Topic T1 in a minute … #LCSM |
 | Israh (Khan)Akhtar @israhkhan Hi everyone I am a pathologist "saving lives one cell at a time" #LCSM https://t.co/bBY45InZmP |
| Janet Freeman-Daily @JFreemanDaily @plh4lisa Howdy Lisa! Jump on in. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: I will announce FIVE topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thanks for joining us, Sarika. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We’ll start with Topic T1 in a minute … #LCSM |
 | Narjust Florez (Duma), M.D. @NarjustFlorezMD @TimAllenMDJD @lcsmchat Forgot the #lcsm |
| Janet Freeman-Daily @JFreemanDaily @NarjustDuma @TimAllenMDJD @lcsmchat It's easy to forget the #LCSM. Glad you joined us! |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD T1: What role does a pathologist play in diagnosing lung cancer? How is a molecular pathologist different from a pathologist? #LCSM |
| #LCSM Chat @lcsmchat @israhkhan Welcome! Thank you for joining. We love our pathologists. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @israhkhan @AmyHDeekenMD Great to see the pathologists jumping in too! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Just in time! #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T1: T1: What role does a pathologist play in diagnosing lung cancer? How is a molecular pathologist different from a pathologist? #LCSM |
| Bob Steele @steele_bob RT @israhkhan: Hi everyone I am a pathologist "saving lives one cell at a time" #LCSM https://t.co/bBY45InZmP |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thanks for joining us, Israh. #LCSM |
| Lisa Moran @plh4lisa Introduction: I'm a nsclc EGFR mutant dx in 2015 on targeted therapy since then. #lcsm |
| Janet Freeman-Daily @JFreemanDaily T1: IIRC, the oncologist collects tissue (or fluid) from the suspected cancer, then the pathologist analyzes it to determine if it IS cancer, and if so, what type. Right? #LCSM |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: T1: T1: What role does a pathologist play in diagnosing lung cancer? How is a molecular pathologist different from a pathologist? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A1: I'll kick things off. Pathologists are the physicians who diagnose whether one’s biopsy tissue is cancerous or not. It’s important, because lesions in the lung can be many things, for example, they can be infectious, or benign tumors, or malignant tumors. #LCSM |
| Bob Steele @steele_bob RT @TimAllenMDJD: A1: A1: I'll kick things off. Pathologists are the physicians who diagnose whether one’s biopsy tissue is cancerous or not. It’s important, because lesions in the lung can be many things, for example, they can be infectious, or benign tumors, or malignant tumors. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: T1: T1: IIRC, the oncologist collects tissue (or fluid) from the suspected cancer, then the pathologist analyzes it to determine if it IS cancer, and if so, what type. Right? #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T1: T1: IIRC, the oncologist collects tissue (or fluid) from the suspected cancer, then the pathologist analyzes it to determine if it IS cancer, and if so, what type. Right? #LCSM |
| KC Dill @kasedill RT @TimAllenMDJD: A1: A1: I'll kick things off. Pathologists are the physicians who diagnose whether one’s biopsy tissue is cancerous or not. It’s important, because lesions in the lung can be many things, for example, they can be infectious, or benign tumors, or malignant tumors. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A1: A1: I'll kick things off. Pathologists are the physicians who diagnose whether one’s biopsy tissue is cancerous or not. It’s important, because lesions in the lung can be many things, for example, they can be infectious, or benign tumors, or malignant tumors. #LCSM |
| Michael Misialek, MD @DrMisialek T1: All treatment begins with the pathologist’s diagnosis #LCSM @Pathologists |
| Janet Freeman-Daily @JFreemanDaily T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| KC Dill @kasedill RT @JFreemanDaily: T1: T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T1: T1: All treatment begins with the pathologist’s diagnosis #LCSM @Pathologists |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T1: T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| Bob Steele @steele_bob RT @JFreemanDaily: T1: T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A1: The Pathologist diagnoses the specific type of lung cancer the patient has, such as adenocarcinoma,squamous cell carcinoma,or small cell carcinoma. These differ in prognoses &, depending on their biomarker test results, abilities to respond to molecular therapies #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrMisialek: T1: T1: All treatment begins with the pathologist’s diagnosis #LCSM @Pathologists |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: T1: T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| #LCSM Chat @lcsmchat #lcsm |
| Janet Freeman-Daily @JFreemanDaily T1: Do all oncologists have a pathologist on staff at their clinic? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A1: A1: The Pathologist diagnoses the specific type of lung cancer the patient has, such as adenocarcinoma,squamous cell carcinoma,or small cell carcinoma. These differ in prognoses &, depending on their biomarker test results, abilities to respond to molecular therapies #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A1: A molecular pathologist is a specialized pathologist with expertise in molecular testing, molecular diagnosis, and molecular treatments. #LCSM |
| KC Dill @kasedill RT @TimAllenMDJD: A1: A1: The Pathologist diagnoses the specific type of lung cancer the patient has, such as adenocarcinoma,squamous cell carcinoma,or small cell carcinoma. These differ in prognoses &, depending on their biomarker test results, abilities to respond to molecular therapies #LCSM |
 | Andrew Chang @ACC001 @lcsmchat #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T1: T1: Do all oncologists have a pathologist on staff at their clinic? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A1: A1: A molecular pathologist is a specialized pathologist with expertise in molecular testing, molecular diagnosis, and molecular treatments. #LCSM |
| KC Dill @kasedill RT @TimAllenMDJD: A1: A1: A molecular pathologist is a specialized pathologist with expertise in molecular testing, molecular diagnosis, and molecular treatments. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A1: A1: The Pathologist diagnoses the specific type of lung cancer the patient has, such as adenocarcinoma,squamous cell carcinoma,or small cell carcinoma. These differ in prognoses &, depending on their biomarker test results, abilities to respond to molecular therapies #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @lcsmchat: #lcsm |
| #LCSM Chat @lcsmchat @ACC001 Welcome! Thanks for joining us. #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @JFreemanDaily: T1: T1: Do all oncologists have a pathologist on staff at their clinic? #LCSM |
| Michael Misialek, MD @DrMisialek T1: In many community hospitals, the general pathologists are also the molecular pathologist #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A1: A1: A molecular pathologist is a specialized pathologist with expertise in molecular testing, molecular diagnosis, and molecular treatments. #LCSM |
| Sarika Jain @drjainsp T1:Molecular pathologist studies submicroscopic aspects of the tumor through examination of DNA, RNA or protein. A molecular pathologist is at the heart of personalized medicine who gives information about markers that predict treatment response and disease progression.#LCSM |
| Bob Steele @steele_bob RT @DrMisialek: T1: T1: In many community hospitals, the general pathologists are also the molecular pathologist #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T1: T1: In many community hospitals, the general pathologists are also the molecular pathologist #LCSM |
| Janet Freeman-Daily @JFreemanDaily @ACC001 @lcsmchat Hi Andrew, we see you! #LCSM |
| #LCSM Chat @lcsmchat RT @drjainsp: T1:Molecular pathologist studies submicroscopic aspects of the tumor through examination of DNA, RNA or protein. A molecular pathologist is at the heart of personalized medicine who gives information about markers that predict treatment response and disease progression.#LCSM |
| Janet Freeman-Daily @JFreemanDaily T1: Pathologists are MDs who chose to focus on analyzing tissue and other specimens rather than treating patients in the clinic. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Not necessarily; however, they should have close connections to their pathology team. Along with radiologists, thoracic surgeons, pulmonologists, etc., pathologists are part of the physician team that diagnoses and manages lung cancer patients. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @drjainsp: T1:Molecular pathologist studies submicroscopic aspects of the tumor through examination of DNA, RNA or protein. A molecular pathologist is at the heart of personalized medicine who gives information about markers that predict treatment response and disease progression.#LCSM |
| Danielle Pardue @Actorielle RT @DrMisialek: T1: T1: In many community hospitals, the general pathologists are also the molecular pathologist #LCSM |
| Bob Steele @steele_bob RT @TimAllenMDJD: Not necessarily; however, they should have close connections to their pathology team. Along with radiologists, thoracic surgeons, pulmonologists, etc., pathologists are part of the physician team that diagnoses and manages lung cancer patients. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrMisialek: T1: T1: In many community hospitals, the general pathologists are also the molecular pathologist #LCSM |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: A1: A1: A molecular pathologist is a specialized pathologist with expertise in molecular testing, molecular diagnosis, and molecular treatments. #LCSM |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: A1: A1: The Pathologist diagnoses the specific type of lung cancer the patient has, such as adenocarcinoma,squamous cell carcinoma,or small cell carcinoma. These differ in prognoses &, depending on their biomarker test results, abilities to respond to molecular therapies #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD #WhyPathologistsMatter #LCSM |
| Danielle Pardue @Actorielle RT @JFreemanDaily: T1: T1: Pathologists also sit on the multi-disciplinary team that decides the best treatment option. #LCSM |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: A1: A1: I'll kick things off. Pathologists are the physicians who diagnose whether one’s biopsy tissue is cancerous or not. It’s important, because lesions in the lung can be many things, for example, they can be infectious, or benign tumors, or malignant tumors. #LCSM |
| #LCSM Chat @lcsmchat Remember to add #LCSM to your tweets so all can see them. |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Not necessarily; however, they should have close connections to their pathology team. Along with radiologists, thoracic surgeons, pulmonologists, etc., pathologists are part of the physician team that diagnoses and manages lung cancer patients. #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T1: T1: Pathologists are MDs who chose to focus on analyzing tissue and other specimens rather than treating patients in the clinic. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Not necessarily; however, they should have close connections to their pathology team. Along with radiologists, thoracic surgeons, pulmonologists, etc., pathologists are part of the physician team that diagnoses and manages lung cancer patients. #LCSM |
| Jill Feldman @jillfeldman4 T1 Do all pathologists look for and test for the same things? How do you know if you are at a place where the pathologist will do thorough testing? #lcsm |
| Bob Steele @steele_bob RT @jillfeldman4: T1 Do all pathologists look for and test for the same things? How do you know if you are at a place where the pathologist will do thorough testing? #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We serve our patients by giving the most accurate diagnoses possible. #PatientsFirst #LCSM |
| H. Jack West, MD @JackWestMD T1: Am I wrong that molecular pathologists are largely limited to larger referral centers? So I think that many/most hospitals don't have a molecular pathologist...or are they more common & widely found? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @lcsmchat: Remember to add #LCSM to your tweets so all can see them. |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T1 Do all pathologists look for and test for the same things? How do you know if you are at a place where the pathologist will do thorough testing? #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: We serve our patients by giving the most accurate diagnoses possible. #PatientsFirst #LCSM |
| KC Dill @kasedill RT @jillfeldman4: T1 Do all pathologists look for and test for the same things? How do you know if you are at a place where the pathologist will do thorough testing? #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Topic T2 is coming up … #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We serve our patients by giving the most accurate diagnoses possible. #PatientsFirst #LCSM |
| #LCSM Chat @lcsmchat RT @JackWestMD: T1: T1: Am I wrong that molecular pathologists are largely limited to larger referral centers? So I think that many/most hospitals don't have a molecular pathologist...or are they more common & widely found? #LCSM |
| Bob Steele @steele_bob RT @JackWestMD: T1: T1: Am I wrong that molecular pathologists are largely limited to larger referral centers? So I think that many/most hospitals don't have a molecular pathologist...or are they more common & widely found? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Topic T2 is coming up … #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @JFreemanDaily Wish it was the case - lack of access to timely pathology results often causes disparities and delays in care #lcsm |
| Bob Steele @steele_bob RT @DevikaDasMD: @JFreemanDaily Wish it was the case - lack of access to timely pathology results often causes disparities and delays in care #lcsm |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @JFreemanDaily Wish it was the case - lack of access to timely pathology results often causes disparities and delays in care #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD They are often associated with academic pathology departments. #LCSM |
| Janet Freeman-Daily @JFreemanDaily .@TimAllenMDJD You are rocking this chat, Mr. Moderator! #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD RT @JackWestMD: T1: T1: Am I wrong that molecular pathologists are largely limited to larger referral centers? So I think that many/most hospitals don't have a molecular pathologist...or are they more common & widely found? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: They are often associated with academic pathology departments. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Pathologists can be patient facing in those situations. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD T2: What happens to tumor tissue after a biopsy? #LCSM |
| #LCSM Chat @lcsmchat Yes he is! #lcsm |
| Michael Misialek, MD @DrMisialek T1: Right, mostly in academic centers, though we in the community fill the role! #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Pathologists can be patient facing in those situations. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T2: T2: What happens to tumor tissue after a biopsy? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Pathologists gotta move fast! And stay accurate! #LCSM |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD T2: Does the tissue fairy whisk it away to a hidden secret lab? ;) #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T1: T1: Right, mostly in academic centers, though we in the community fill the role! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Following in the footsteps of greatness. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Pathologists gotta move fast! And stay accurate! #LCSM |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: T2: T2: What happens to tumor tissue after a biopsy? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrMisialek: T1: T1: Right, mostly in academic centers, though we in the community fill the role! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A2: The tissue is processed so that it lies in a block of paraffin; the block is then thinly sectioned & a very thin piece of the tissue is cut and put on a glass slide. #LCSM |
| Danielle Pardue @Actorielle RT @jillfeldman4: T1 Do all pathologists look for and test for the same things? How do you know if you are at a place where the pathologist will do thorough testing? #lcsm |
| Lisa Moran @plh4lisa @JFreemanDaily @TimAllenMDJD When does the wax come in? #lcsm |
| Jill Feldman @jillfeldman4 T2 What is a frozen section and how often is it accurate? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A2: Then the tissue is then stained so that it can be easily examined. After it is labeled & covered so the tissue doesn’t get lost, it is ready to be examined by the pathologist. #LCSM |
 | sic @kimvie RT @DevikaDasMD: @JFreemanDaily Wish it was the case - lack of access to timely pathology results often causes disparities and delays in care #lcsm |
| Danielle Pardue @Actorielle RT @drjainsp: T1:Molecular pathologist studies submicroscopic aspects of the tumor through examination of DNA, RNA or protein. A molecular pathologist is at the heart of personalized medicine who gives information about markers that predict treatment response and disease progression.#LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A2: A2: The tissue is processed so that it lies in a block of paraffin; the block is then thinly sectioned & a very thin piece of the tissue is cut and put on a glass slide. #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat Depends on the amount of tissue obtained. In this age of extended testing, I prefer not seeing fine needle aspiration which often provides insufficient information and could lead to more procedures and delays #lcsm |
| Janet Freeman-Daily @JFreemanDaily @plh4lisa @TimAllenMDJD Are you asking about when the paraffin gets applied to slides? #LCSM |
| Bob Steele @steele_bob RT @DevikaDasMD: @TimAllenMDJD @lcsmchat Depends on the amount of tissue obtained. In this age of extended testing, I prefer not seeing fine needle aspiration which often provides insufficient information and could lead to more procedures and delays #lcsm |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @TimAllenMDJD @lcsmchat Depends on the amount of tissue obtained. In this age of extended testing, I prefer not seeing fine needle aspiration which often provides insufficient information and could lead to more procedures and delays #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Frozen sections are intraoperative consultations where the pathologist directs the surgeon on how to proceed with the patient's surgery. The pathologist looks at the tissue within a few minutes of it being removed from the patient. #LCSM |
| Michael Misialek, MD @DrMisialek T2 Great video from @Pathologists on the journey of tissue #LCSM https://t.co/JQlUkqkGW7 |
| Betsy @MAmaskwearer @TimAllenMDJD Patient facing? #lcsm |
| #LCSM Chat @lcsmchat #lcsm |
| Bob Steele @steele_bob RT @TimAllenMDJD: Frozen sections are intraoperative consultations where the pathologist directs the surgeon on how to proceed with the patient's surgery. The pathologist looks at the tissue within a few minutes of it being removed from the patient. #LCSM |
| Lisa Moran @plh4lisa @JFreemanDaily @TimAllenMDJD Yes. I saw I asked after the A was posted. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD T2: Does all the collected tissue get put in one block of paraffin, or is it divided into multiple blocks so you can make more slides to support more tests? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD The paraffin is used as part of the laboratory's processing of the patient's tissue, in order that a glass slide can be made for the pathologist to review and make a diagnosis. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T2 What is a frozen section and how often is it accurate? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A2: A2: Then the tissue is then stained so that it can be easily examined. After it is labeled & covered so the tissue doesn’t get lost, it is ready to be examined by the pathologist. #LCSM |
 | Dr. David Tom Cooke @DavidCookeMD T2 A frozen section is a quick "H and E" look at tissue, often prepared in a special pathology lab in the operating rooms. This is a valuable pathology service that helps surgeons decide such thins as do we have the right specimen, and are the resection margins ok. #LCSM |
| Janet Freeman-Daily @JFreemanDaily @AmyHDeekenMD @TimAllenMDJD Love it! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @lcsmchat: #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Frozen sections are intraoperative consultations where the pathologist directs the surgeon on how to proceed with the patient's surgery. The pathologist looks at the tissue within a few minutes of it being removed from the patient. #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T2 Great video from @Pathologists on the journey of tissue #LCSM https://t.co/JQlUkqkGW7 |
| KC Dill @kasedill @DrMisialek @Pathologists Bookmarking #lcsm |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @TimAllenMDJD T2: @TimAllenMDJD T2: Does all the collected tissue get put in one block of paraffin, or is it divided into multiple blocks so you can make more slides to support more tests? #LCSM |
 | Jennifer Ersek @JLErsek Hey y’all! Late tonight but catching up... #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: The paraffin is used as part of the laboratory's processing of the patient's tissue, in order that a glass slide can be made for the pathologist to review and make a diagnosis. #LCSM |
| Danielle Pardue @Actorielle RT @lcsmchat: #lcsm |
| Israh (Khan)Akhtar @israhkhan #LCSM these are the cells we look for to make diagnosis each and every cell is important This is an example of small cell carcinoma, worst prognosis,molecular is not helpful. It is a form of high grade neuroendocrine carcinoma https://t.co/ZC3pEtig6f |
| Sarika Jain @drjainsp T2:DNA or RNA will be extracted if the diagnosis of lung cancer is made and sent for molecular testing, if appropriate.#LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A2: A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: T2 A frozen section is a quick "H and E" look at tissue, often prepared in a special pathology lab in the operating rooms. This is a valuable pathology service that helps surgeons decide such thins as do we have the right specimen, and are the resection margins ok. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD With the patient like our colleagues. Pathologists nonetheless spend lots of time taking care of our patients and never seeing them. We're still there for them though! #LCSM |
| Janet Freeman-Daily @JFreemanDaily T2: Does all the processing of tissue happen at the clinic that collected it? Does any fresh tissue get sent elsewhere? #LCSM |
| Bob Steele @steele_bob RT @DrMisialek: T2 Great video from @Pathologists on the journey of tissue #LCSM https://t.co/JQlUkqkGW7 |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: A2: A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM these are the cells we look for to make diagnosis each and every cell is important This is an example of small cell carcinoma, worst prognosis,molecular is not helpful. It is a form of high grade neuroendocrine carcinoma https://t.co/ZC3pEtig6f |
| Devika Das, MD, MSHQS @DevikaDasMD RT @DavidCookeMD: T2 A frozen section is a quick "H and E" look at tissue, often prepared in a special pathology lab in the operating rooms. This is a valuable pathology service that helps surgeons decide such thins as do we have the right specimen, and are the resection margins ok. #LCSM |
| Bob Steele @steele_bob RT @israhkhan: #LCSM these are the cells we look for to make diagnosis each and every cell is important This is an example of small cell carcinoma, worst prognosis,molecular is not helpful. It is a form of high grade neuroendocrine carcinoma https://t.co/ZC3pEtig6f |
| #LCSM Chat @lcsmchat RT @drjainsp: T2:DNA or RNA will be extracted if the diagnosis of lung cancer is made and sent for molecular testing, if appropriate.#LCSM |
 | Eric Konnick, MD @Molecular_MD RT @DrMisialek: T1: T1: All treatment begins with the pathologist’s diagnosis #LCSM @Pathologists |
| Devika Das, MD, MSHQS @DevikaDasMD RT @TimAllenMDJD: A2: A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD It's where I get to tell you what to do!!! #LCSM |
| H. Jack West, MD @JackWestMD RT @TimAllenMDJD: Frozen sections are intraoperative consultations where the pathologist directs the surgeon on how to proceed with the patient's surgery. The pathologist looks at the tissue within a few minutes of it being removed from the patient. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A2: A2: The tissue is processed so that it lies in a block of paraffin; the block is then thinly sectioned & a very thin piece of the tissue is cut and put on a glass slide. #LCSM |
| Upstage Lung Cancer @UpstageLungCanc RT @TimAllenMDJD: A2: A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @drjainsp: T2:DNA or RNA will be extracted if the diagnosis of lung cancer is made and sent for molecular testing, if appropriate.#LCSM |
| KC Dill @kasedill RT @TimAllenMDJD: A2: A2: Once a diagnosis of lung cancer is made by the pathologist, additional slides from the tissue block can be stained to better characterize the cancer (adenocarcinoma, squamous cell carcinoma, etc.) & when appropriate, slides can be stained for molecular & immuno testing. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: With the patient like our colleagues. Pathologists nonetheless spend lots of time taking care of our patients and never seeing them. We're still there for them though! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: T2 What is a frozen section and how often is it accurate? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM these are the cells we look for to make diagnosis each and every cell is important This is an example of small cell carcinoma, worst prognosis,molecular is not helpful. It is a form of high grade neuroendocrine carcinoma https://t.co/ZC3pEtig6f |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T2: T2: Does all the processing of tissue happen at the clinic that collected it? Does any fresh tissue get sent elsewhere? #LCSM |
| Upstage Lung Cancer @UpstageLungCanc RT @lcsmchat: #lcsm |
| H. Jack West, MD @JackWestMD How often can you make a clear diagnosis from that? #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @AmyHDeekenMD @lcsmchat @JFreemanDaily @TimAllenMDJD Such a critical step #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Welcome to Pathology night! #LCSM |
| Lisa Moran @plh4lisa @TimAllenMDJD #lcsm |
| #LCSM Chat @lcsmchat RT @JackWestMD: How often can you make a clear diagnosis from that? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD A2 Often for research purposes. For example we have a biorepository where we bank #LungCancer tissue for potential research later. #LCSM |
| Danielle Pardue @Actorielle RT @JFreemanDaily: T2: T2: Does all the processing of tissue happen at the clinic that collected it? Does any fresh tissue get sent elsewhere? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We’ll shift to Topic T3 next … #LCSM |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: A2 Often for research purposes. For example we have a biorepository where we bank #LungCancer tissue for potential research later. #LCSM |
| Narjust Florez (Duma), M.D. @NarjustFlorezMD @JackWestMD @lcsmchat Good question! #lcsm |
| Upstage Lung Cancer @UpstageLungCanc RT @JackWestMD: How often can you make a clear diagnosis from that? #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We’ll shift to Topic T3 next … #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD T3: How does a pathologist know if a cell is cancerous? How can they tell what type of lung cancer it is (e.g., small cell vs adenocarcinoma)? #LCSM |
| Bob Steele @steele_bob RT @JFreemanDaily: T2: T2: Does all the processing of tissue happen at the clinic that collected it? Does any fresh tissue get sent elsewhere? #LCSM |
| KC Dill @kasedill RT @DavidCookeMD: A2 Often for research purposes. For example we have a biorepository where we bank #LungCancer tissue for potential research later. #LCSM |
| Jill Feldman @jillfeldman4 T2 Is tissue still the issue with lung biopsies with regards to getting enough for multiple testing? #LCSM |
| Janet Freeman-Daily @JFreemanDaily @kasedill @DrMisialek @Pathologists Remember, all the questions and answers in this chat will be captured in the transcript and archived on the https://t.co/mnTf02isUu website #LCSM |
| Janet Freeman-Daily @JFreemanDaily @JLErsek Hey Jennifer! #LCSM |
| Israh (Khan)Akhtar @israhkhan #LCSM This is an example of Squamous cell carcinoma. In this immunotherapy is helpful (treatment by Keytruda). So if tumor cells are positive for PDL1 these patients generally are responsive to Keytruda. The immunostain here used is p40 (slide 3) https://t.co/SOGHt6AnN5 |
| Lisa Moran @plh4lisa @TimAllenMDJD What is H and E? #lcsm |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: T3: T3: How does a pathologist know if a cell is cancerous? How can they tell what type of lung cancer it is (e.g., small cell vs adenocarcinoma)? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Sometimes tissue is sent for special studies, for example, when lymphoma is suspected. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T3: T3: How does a pathologist know if a cell is cancerous? How can they tell what type of lung cancer it is (e.g., small cell vs adenocarcinoma)? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM This is an example of Squamous cell carcinoma. In this immunotherapy is helpful (treatment by Keytruda). So if tumor cells are positive for PDL1 these patients generally are responsive to Keytruda. The immunostain here used is p40 (slide 3) https://t.co/SOGHt6AnN5 |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T2 Is tissue still the issue with lung biopsies with regards to getting enough for multiple testing? #LCSM |
| Janet Freeman-Daily @JFreemanDaily T2: How long must pathologists train to be able to recognize the different cell types under a microscope? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @israhkhan: #LCSM these are the cells we look for to make diagnosis each and every cell is important This is an example of small cell carcinoma, worst prognosis,molecular is not helpful. It is a form of high grade neuroendocrine carcinoma https://t.co/ZC3pEtig6f |
| Dr. David Tom Cooke @DavidCookeMD Although not always the case, sometimes if a nodule is suspicious enough, a surgeon will go straight to surgery. Wedge out the mass, and perform a frozen section. If cancer on frozen, perform lobectomy if appropriate. #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @kasedill @DrMisialek @Pathologists Remember, all the questions and answers in this chat will be captured in the transcript and archived on the https://t.co/mnTf02isUu website #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: With the patient like our colleagues. Pathologists nonetheless spend lots of time taking care of our patients and never seeing them. We're still there for them though! #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM This is an example of Squamous cell carcinoma. In this immunotherapy is helpful (treatment by Keytruda). So if tumor cells are positive for PDL1 these patients generally are responsive to Keytruda. The immunostain here used is p40 (slide 3) https://t.co/SOGHt6AnN5 |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD It's the stain used to color the tissue, which is essentially colorless when it is sectioned and put on a glass slide. It turns the tissue blue and pink. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A3: Pathologists use diagnostic criteria they learn in their training in order to diagnose diseases, including the various types of lung cancer. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Sometimes tissue is sent for special studies, for example, when lymphoma is suspected. #LCSM |
| Lung Cancer Sux @LungCancerSux T2 is there ever enough tissue from fna to send it out for additional testing, as in a 3a dx ? #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: T2: T2: How long must pathologists train to be able to recognize the different cell types under a microscope? #LCSM |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: Although not always the case, sometimes if a nodule is suspicious enough, a surgeon will go straight to surgery. Wedge out the mass, and perform a frozen section. If cancer on frozen, perform lobectomy if appropriate. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: A2 Often for research purposes. For example we have a biorepository where we bank #LungCancer tissue for potential research later. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: It's the stain used to color the tissue, which is essentially colorless when it is sectioned and put on a glass slide. It turns the tissue blue and pink. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A3: A3: Pathologists use diagnostic criteria they learn in their training in order to diagnose diseases, including the various types of lung cancer. #LCSM |
| #LCSM Chat @lcsmchat RT @LungCancerSux: T2 is there ever enough tissue from fna to send it out for additional testing, as in a 3a dx ? #LCSM |
 | Justin Bateman @JJBtweetin @plh4lisa @TimAllenMDJD Hematoxylin and eosin stain. We use it all the time in pathology. It basically gives translucent thin tissue slides colour. #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @JackWestMD: How often can you make a clear diagnosis from that? #LCSM |
 | bingo @bingohanley RT @JackWestMD: Dr. Jack West here, just having relocated to at least intermittently sunny LA (though recently distressingly rainy & reminiscent of Seattle), & now working at @CityofHope. Very happy to join! #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @jillfeldman4 @lcsmchat In my experience as a medical oncologist - absolutely yes ! Research interest of mine #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: T3: T3: How does a pathologist know if a cell is cancerous? How can they tell what type of lung cancer it is (e.g., small cell vs adenocarcinoma)? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @plh4lisa: @TimAllenMDJD What is H and E? #lcsm |
| #LCSM Chat @lcsmchat RT @JJBtweetin: @plh4lisa @TimAllenMDJD Hematoxylin and eosin stain. We use it all the time in pathology. It basically gives translucent thin tissue slides colour. #lcsm |
| Bob Steele @steele_bob RT @LungCancerSux: T2 is there ever enough tissue from fna to send it out for additional testing, as in a 3a dx ? #LCSM |
| Israh (Khan)Akhtar @israhkhan #LCSM This is an example of adenocarcinom, which is big on molecular. We get Alk, ROS, EGFR, BRAF and KRAS on these specimens.Picture 3 is cell block on which molecular testing wil be performed eventually https://t.co/PDJ7xdkEQi |
| Janet Freeman-Daily @JFreemanDaily @israhkhan Hold on -- what's a stain? I hear about them, but not sure what it is. #LCSM |
| Dianne Grunes @DrGrunes @plh4lisa @TimAllenMDJD It stands for hemotoxylin and eosin. It is a routine stain that helps us see the tissue. It stains different parts of the cell blue and pink and allows us to see the tumor #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DavidCookeMD: Although not always the case, sometimes if a nodule is suspicious enough, a surgeon will go straight to surgery. Wedge out the mass, and perform a frozen section. If cancer on frozen, perform lobectomy if appropriate. #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM This is an example of adenocarcinom, which is big on molecular. We get Alk, ROS, EGFR, BRAF and KRAS on these specimens.Picture 3 is cell block on which molecular testing wil be performed eventually https://t.co/PDJ7xdkEQi |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @israhkhan Hold on -- what's a stain? I hear about them, but not sure what it is. #LCSM |
| Michael Misialek, MD @DrMisialek T3: Pathologists train for years to recognize cancer cells, and never stop learning! Sometimes it can be very difficult to diagnose. #LCSM |
| Bob Steele @steele_bob RT @israhkhan: #LCSM This is an example of adenocarcinom, which is big on molecular. We get Alk, ROS, EGFR, BRAF and KRAS on these specimens.Picture 3 is cell block on which molecular testing wil be performed eventually https://t.co/PDJ7xdkEQi |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: Although not always the case, sometimes if a nodule is suspicious enough, a surgeon will go straight to surgery. Wedge out the mass, and perform a frozen section. If cancer on frozen, perform lobectomy if appropriate. #LCSM |
| #LCSM Chat @lcsmchat RT @DrGrunes: @plh4lisa @TimAllenMDJD It stands for hemotoxylin and eosin. It is a routine stain that helps us see the tissue. It stains different parts of the cell blue and pink and allows us to see the tumor #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: It's the stain used to color the tissue, which is essentially colorless when it is sectioned and put on a glass slide. It turns the tissue blue and pink. #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T3: T3: Pathologists train for years to recognize cancer cells, and never stop learning! Sometimes it can be very difficult to diagnose. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrGrunes: @plh4lisa @TimAllenMDJD It stands for hemotoxylin and eosin. It is a routine stain that helps us see the tissue. It stains different parts of the cell blue and pink and allows us to see the tumor #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A3: A3: Pathologists use diagnostic criteria they learn in their training in order to diagnose diseases, including the various types of lung cancer. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM This is an example of adenocarcinom, which is big on molecular. We get Alk, ROS, EGFR, BRAF and KRAS on these specimens.Picture 3 is cell block on which molecular testing wil be performed eventually https://t.co/PDJ7xdkEQi |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: @israhkhan Hold on -- what's a stain? I hear about them, but not sure what it is. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD These cells are "stained" so that they will show up; otherwise the tissue is essentially clear. #LCSM |
| Sarika Jain @drjainsp @TimAllenMDJD Fresh tissue can also used for molecular studies which can actually be a better sample as it skips all the processing.#LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD I haven't stopped learning yet! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Sometimes tissue is sent for special studies, for example, when lymphoma is suspected. #LCSM |
| Andrew Chang @ACC001 A2: by size - surgical is usually a wedge of lung that includes a suspicious nodule, core needle usually by CT or bronchoscope, fine needle aspirate also by CT or bronch #LCSM |
| Dianne Grunes @DrGrunes @JFreemanDaily Following medical school, most residencies in pathology are 4 years. Following that, most spend another year or two (or more) doing specialized fellowships such as in lung pathology, or molecular pathology #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: These cells are "stained" so that they will show up; otherwise the tissue is essentially clear. #LCSM |
 | Stephen Yip, MD/PhD FRCPC @Sty_md RT @drjainsp: T1:Molecular pathologist studies submicroscopic aspects of the tumor through examination of DNA, RNA or protein. A molecular pathologist is at the heart of personalized medicine who gives information about markers that predict treatment response and disease progression.#LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @drjainsp: @TimAllenMDJD Fresh tissue can also used for molecular studies which can actually be a better sample as it skips all the processing.#LCSM |
| #LCSM Chat @lcsmchat RT @drjainsp: @TimAllenMDJD Fresh tissue can also used for molecular studies which can actually be a better sample as it skips all the processing.#LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: I haven't stopped learning yet! #LCSM |
| #LCSM Chat @lcsmchat RT @ACC001: A2: A2: by size - surgical is usually a wedge of lung that includes a suspicious nodule, core needle usually by CT or bronchoscope, fine needle aspirate also by CT or bronch #LCSM |
| #LCSM Chat @lcsmchat RT @DrGrunes: @JFreemanDaily Following medical school, most residencies in pathology are 4 years. Following that, most spend another year or two (or more) doing specialized fellowships such as in lung pathology, or molecular pathology #lcsm |
| Bob Steele @steele_bob RT @ACC001: A2: A2: by size - surgical is usually a wedge of lung that includes a suspicious nodule, core needle usually by CT or bronchoscope, fine needle aspirate also by CT or bronch #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JJBtweetin: @plh4lisa @TimAllenMDJD Hematoxylin and eosin stain. We use it all the time in pathology. It basically gives translucent thin tissue slides colour. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrGrunes: @JFreemanDaily Following medical school, most residencies in pathology are 4 years. Following that, most spend another year or two (or more) doing specialized fellowships such as in lung pathology, or molecular pathology #lcsm |
| Jill Feldman @jillfeldman4 T2 What does a pathology report include? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @ACC001: A2: A2: by size - surgical is usually a wedge of lung that includes a suspicious nodule, core needle usually by CT or bronchoscope, fine needle aspirate also by CT or bronch #LCSM |
| Janet Freeman-Daily @JFreemanDaily @LungCancerSux Can you explain your question in more basic terms for those who aren't as familiar with them? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @drjainsp: @TimAllenMDJD Fresh tissue can also used for molecular studies which can actually be a better sample as it skips all the processing.#LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Topic T4 is coming up … #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @JJBtweetin: @plh4lisa @TimAllenMDJD Hematoxylin and eosin stain. We use it all the time in pathology. It basically gives translucent thin tissue slides colour. #lcsm |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T2 What does a pathology report include? #LCSM |
| Janet Freeman-Daily @JFreemanDaily @JJBtweetin @plh4lisa @TimAllenMDJD Hey Justin, welcome! #LCSM |
| Dianne Grunes @DrGrunes @drjainsp @TimAllenMDJD I think this is why many have had good results using the cytology smears. No formalin fixation. #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @DrGrunes: @plh4lisa @TimAllenMDJD It stands for hemotoxylin and eosin. It is a routine stain that helps us see the tissue. It stains different parts of the cell blue and pink and allows us to see the tumor #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Topic T4 is coming up … #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @ACC001: A2: A2: by size - surgical is usually a wedge of lung that includes a suspicious nodule, core needle usually by CT or bronchoscope, fine needle aspirate also by CT or bronch #LCSM |
| KC Dill @kasedill @drjainsp @TimAllenMDJD Is their staining involved with molecular testing? #lcsm |
| #LCSM Chat @lcsmchat RT @DrGrunes: @drjainsp @TimAllenMDJD I think this is why many have had good results using the cytology smears. No formalin fixation. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrGrunes: @drjainsp @TimAllenMDJD I think this is why many have had good results using the cytology smears. No formalin fixation. #lcsm |
| H. Jack West, MD @JackWestMD T3: serious Q, not trying to denigrate anyone, but knowing this research is being done: how close do you feel we are to AI-based algorithms being able to reliably identify cancer by pattern recognition? Could help in underserved places eventually. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DrGrunes: @JFreemanDaily Following medical school, most residencies in pathology are 4 years. Following that, most spend another year or two (or more) doing specialized fellowships such as in lung pathology, or molecular pathology #lcsm |
 | Raghavendra Pillappa @raghupillappa RT @israhkhan: #LCSM This is an example of Squamous cell carcinoma. In this immunotherapy is helpful (treatment by Keytruda). So if tumor cells are positive for PDL1 these patients generally are responsive to Keytruda. The immunostain here used is p40 (slide 3) https://t.co/SOGHt6AnN5 |
| Betsy @MAmaskwearer @drjainsp @TimAllenMDJD Does staining interfere with molecular studies? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: T2 What does a pathology report include? #LCSM |
| Jill Feldman @jillfeldman4 @TimAllenMDJD Should patients ever get a second opinion on their pathology results? #LCSM |
| #LCSM Chat @lcsmchat RT @JackWestMD: T3: serious Q, not trying to denigrate anyone, but knowing this research is being done: T3: serious Q, not trying to denigrate anyone, but knowing this research is being done: how close do you feel we are to AI-based algorithms being able to reliably identify cancer by pattern recognition? Could help in underserved places eventually. #LCSM |
| #LCSM Chat @lcsmchat RT @wildwestannie: @drjainsp @TimAllenMDJD Does staining interfere with molecular studies? #LCSM |
| Michael Misialek, MD @DrMisialek T4: Top 10 Reasons to Meet Your Pathologist https://t.co/KmbPvQmdk0 #LCSM https://t.co/1VcN5UY3aW |
| #LCSM Chat @lcsmchat RT @jillfeldman4: @TimAllenMDJD Should patients ever get a second opinion on their pathology results? #LCSM |
| Janet Freeman-Daily @JFreemanDaily @DrGrunes @drjainsp @TimAllenMDJD What's a cytology smear? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Typically it includes the gross description of the tissue, a microscopic description, and a diagnosis. It may also include a comment if necessary to further clarify something about the case. #LCSM |
| Dr. David Tom Cooke @DavidCookeMD Hey @JackWestMD congrats on your new position at @cityofhope ! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD T4: How does a molecular pathologist decide what biomarker tests to do? #LCSM |
| #LCSM Chat @lcsmchat RT @DrMisialek: T4: T4: Top 10 Reasons to Meet Your Pathologist https://t.co/KmbPvQmdk0 #LCSM https://t.co/1VcN5UY3aW |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: @TimAllenMDJD Should patients ever get a second opinion on their pathology results? #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @DrGrunes @drjainsp @TimAllenMDJD What's a cytology smear? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD It has nothing to do with Bagels. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Typically it includes the gross description of the tissue, a microscopic description, and a diagnosis. It may also include a comment if necessary to further clarify something about the case. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T4: T4: How does a molecular pathologist decide what biomarker tests to do? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Yes. If there is any concern or confusion, certainly consider getting one. Your diagnosis is too important! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Typically it includes the gross description of the tissue, a microscopic description, and a diagnosis. It may also include a comment if necessary to further clarify something about the case. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JackWestMD: T3: serious Q, not trying to denigrate anyone, but knowing this research is being done: T3: serious Q, not trying to denigrate anyone, but knowing this research is being done: how close do you feel we are to AI-based algorithms being able to reliably identify cancer by pattern recognition? Could help in underserved places eventually. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @kasedill: @drjainsp @TimAllenMDJD Is their staining involved with molecular testing? #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A4: The appropriate biomarker testing is based on the type of lung cancer present. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Yes. If there is any concern or confusion, certainly consider getting one. Your diagnosis is too important! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: T4: T4: How does a molecular pathologist decide what biomarker tests to do? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Actually... #LCSM |
| Jennifer Ersek @JLErsek @DrGrunes @JFreemanDaily Another important role in the pathology department is that of the pathology assistant. PAs help prep the tissue for review by the pathologist. Many 2 year programs available (+ prerequisites). #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A4: A4: The appropriate biomarker testing is based on the type of lung cancer present. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Absolutely! Congrats, Jack! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Yes. If there is any concern or confusion, certainly consider getting one. Your diagnosis is too important! #LCSM |
| #LCSM Chat @lcsmchat RT @JLErsek: @DrGrunes @JFreemanDaily Another important role in the pathology department is that of the pathology assistant. PAs help prep the tissue for review by the pathologist. Many 2 year programs available (+ prerequisites). #LCSM |
| Sarika Jain @drjainsp @kasedill @TimAllenMDJD No. For mutational testing we will amplify the DNA and sequence it, which can be done in different ways.#LCSM |
| Dr. David Tom Cooke @DavidCookeMD @UCD_Cancer and @UCDavisHealth by nature very collaborative. Visitors are shocked that we all get along. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A4: Most molecular biomarker testing is performed on lung adenocarcinomas rather than on squamous cell carcinomas or small cell carcinomas. That is because adenocarcinomas may respond to molecular therapies when the biomarker indicates. #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @jillfeldman4 @lcsmchat @TimAllenMDJD Depends on the experience of the pathologist with the said tumor type - a second opinion if needed should go to a high volume center. It happens all the time at my tertiary care center with referrals #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A4: A4: The appropriate biomarker testing is based on the type of lung cancer present. #LCSM |
| Lisa Moran @plh4lisa What's the difference between tissue and blood pathology? #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @JLErsek: @DrGrunes @JFreemanDaily Another important role in the pathology department is that of the pathology assistant. PAs help prep the tissue for review by the pathologist. Many 2 year programs available (+ prerequisites). #LCSM |
| Dr. David Tom Cooke @DavidCookeMD You can sell your umbrella. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Yes! A great addition to the laboratory team! #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A4: A4: Most molecular biomarker testing is performed on lung adenocarcinomas rather than on squamous cell carcinomas or small cell carcinomas. That is because adenocarcinomas may respond to molecular therapies when the biomarker indicates. #LCSM |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @jillfeldman4 @lcsmchat @TimAllenMDJD Depends on the experience of the pathologist with the said tumor type - a second opinion if needed should go to a high volume center. It happens all the time at my tertiary care center with referrals #lcsm |
| Jill Feldman @jillfeldman4 T4 How often is biomarker testing done by the pathologist at hospital/cancer center compared to having tissue sent out #LCSM |
| #LCSM Chat @lcsmchat RT @plh4lisa: What's the difference between tissue and blood pathology? #lcsm |
| Israh (Khan)Akhtar @israhkhan #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
 | Jenny Jones @Jenny_Writer RT @RadiologyACR: Using #CT with radiation doses as low as those from plain x-rays, researchers were able to catch sold lung nodules with 98.5 percent sensitivity and 100 percent specificity via @RadiologyBiz https://t.co/nlPO2QVSJZ #lcsm #lungcancer |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T4 How often is biomarker testing done by the pathologist at hospital/cancer center compared to having tissue sent out #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD @drjainsp , please explain further! #LCSM |
| H. Jack West, MD @JackWestMD RT @TimAllenMDJD: A4: A4: Most molecular biomarker testing is performed on lung adenocarcinomas rather than on squamous cell carcinomas or small cell carcinomas. That is because adenocarcinomas may respond to molecular therapies when the biomarker indicates. #LCSM |
| Bob Steele @steele_bob RT @israhkhan: #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A4: A4: Most molecular biomarker testing is performed on lung adenocarcinomas rather than on squamous cell carcinomas or small cell carcinomas. That is because adenocarcinomas may respond to molecular therapies when the biomarker indicates. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A4: There’s a recent paper that discusses lung cancer biomarker testing. https://t.co/IMlx0HRx0y #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DevikaDasMD: @jillfeldman4 @lcsmchat @TimAllenMDJD Depends on the experience of the pathologist with the said tumor type - a second opinion if needed should go to a high volume center. It happens all the time at my tertiary care center with referrals #lcsm |
| Dr. David Tom Cooke @DavidCookeMD A4 It depends. More and more larger comprehensive cancer centers are doing tests in house. But the lion share of centers likely send out for large panel testing. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: @drjainsp , please explain further! #LCSM |
| Dr. David Tom Cooke @DavidCookeMD RT @TimAllenMDJD: A4: A4: There’s a recent paper that discusses lung cancer biomarker testing. https://t.co/IMlx0HRx0y #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A4: A4: There’s a recent paper that discusses lung cancer biomarker testing. https://t.co/IMlx0HRx0y #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: A4 It depends. More and more larger comprehensive cancer centers are doing tests in house. But the lion share of centers likely send out for large panel testing. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @plh4lisa: What's the difference between tissue and blood pathology? #lcsm |
| Lisa Moran @plh4lisa @TimAllenMDJD Will this change as more and more biomarkers are being found in different primary cancers? #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @israhkhan: #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
| Jill Feldman @jillfeldman4 T4 Does the biomarker testing results become part of the original pathology report regardless of where testing is done? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A4: A4: There’s a recent paper that discusses lung cancer biomarker testing. https://t.co/IMlx0HRx0y #LCSM |
| #LCSM Chat @lcsmchat #lcsm |
| Dr. David Tom Cooke @DavidCookeMD I view AI in pathology and radiology, similar to robotics in surgery. These technologies will be adjunct tools used by the modern pathologist and radiologist. Not disruptive replacement. #HumansAreUnderrated #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: A4 It depends. More and more larger comprehensive cancer centers are doing tests in house. But the lion share of centers likely send out for large panel testing. #LCSM |
| Justin Bateman @JJBtweetin @JackWestMD I think AI will be very helpful in the near future. But AI will never advocate for patients or contribute to multidisciplinary teams the way pathologists do. Just look at this thread! #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat A4 This is where communication with the medical oncologist is essential. Limited number of molecular markers vs need to do large panel sequencing. Pathology is thus a critical member of the multidisciplinary team #lcsm |
| Dianne Grunes @DrGrunes @JFreemanDaily @drjainsp @TimAllenMDJD It is what we look at when evaluating very small biopsies. We are looking at individual cells rather than the tissue #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @lcsmchat: #lcsm |
| H. Jack West, MD @JackWestMD A4: so, largely based on the probability of finding result that would change management for that particular type of cancer, along w/the timing of getting results back. In reality, this is also shaped by how much tissue is available, at least if scarce & choices must be made #LCSM |
| #LCSM Chat @lcsmchat RT @plh4lisa: @TimAllenMDJD Will this change as more and more biomarkers are being found in different primary cancers? #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @jillfeldman4: T4 Does the biomarker testing results become part of the original pathology report regardless of where testing is done? #LCSM |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T4 Does the biomarker testing results become part of the original pathology report regardless of where testing is done? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DavidCookeMD: A4 It depends. More and more larger comprehensive cancer centers are doing tests in house. But the lion share of centers likely send out for large panel testing. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @plh4lisa: @TimAllenMDJD Will this change as more and more biomarkers are being found in different primary cancers? #lcsm |
| Jill Feldman @jillfeldman4 @DavidCookeMD What is the time difference for getting results? #LCSM |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: I view AI in pathology and radiology, similar to robotics in surgery. These technologies will be adjunct tools used by the modern pathologist and radiologist. Not disruptive replacement. #HumansAreUnderrated #LCSM |
| Joni Fowler, PharmD, BCPP @jfowlerpharmd @TimAllenMDJD Can you elaborate on when/why “IO testing” is done (PD-L1, TMB, T-cell inflamed GEP) & how it differs from EGFR/ALK/etc? Are these all from same tissue sample and done at same time? #lcsm |
| Bob Steele @steele_bob RT @TimAllenMDJD: A4: A4: There’s a recent paper that discusses lung cancer biomarker testing. https://t.co/IMlx0HRx0y #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A4: Here are the revised lung cancer biomarker guidelines. https://t.co/8NFvL3rewb #LCSM |
| #LCSM Chat @lcsmchat RT @JJBtweetin: @JackWestMD I think AI will be very helpful in the near future. But AI will never advocate for patients or contribute to multidisciplinary teams the way pathologists do. Just look at this thread! #LCSM |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @TimAllenMDJD @lcsmchat A4 This is where communication with the medical oncologist is essential. Limited number of molecular markers vs need to do large panel sequencing. Pathology is thus a critical member of the multidisciplinary team #lcsm |
| #LCSM Chat @lcsmchat RT @DrGrunes: @JFreemanDaily @drjainsp @TimAllenMDJD It is what we look at when evaluating very small biopsies. We are looking at individual cells rather than the tissue #lcsm |
| Dr. David Tom Cooke @DavidCookeMD T4 Not necessarily immediately. However if done as a send out, often is added on to the original report as an addendum. #LCSM |
| #LCSM Chat @lcsmchat RT @JackWestMD: A4: A4: so, largely based on the probability of finding result that would change management for that particular type of cancer, along w/the timing of getting results back. In reality, this is also shaped by how much tissue is available, at least if scarce & choices must be made #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JackWestMD: A4: A4: so, largely based on the probability of finding result that would change management for that particular type of cancer, along w/the timing of getting results back. In reality, this is also shaped by how much tissue is available, at least if scarce & choices must be made #LCSM |
| Janet Freeman-Daily @JFreemanDaily @plh4lisa @TimAllenMDJD It will change when reliable biomarkers are found for squamous LC, and treatments are available. We have a ways to go yet. But some known adeno targets are also in squamous cell LC. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DrGrunes: @JFreemanDaily @drjainsp @TimAllenMDJD It is what we look at when evaluating very small biopsies. We are looking at individual cells rather than the tissue #lcsm |
| Israh (Khan)Akhtar @israhkhan #LCSM Not all cases are straightforward. Sometimes immunostains dont work and we cant exactly classify tumor as adenocarcinoma or squamous cell carcinoma,or even large cell neuroendocrine Ca and in that case call it Nonsmall cell carcinoma (NSCLC) NOS https://t.co/AgxS2HXVxk |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DevikaDasMD: @TimAllenMDJD @lcsmchat A4 This is where communication with the medical oncologist is essential. Limited number of molecular markers vs need to do large panel sequencing. Pathology is thus a critical member of the multidisciplinary team #lcsm |
| Dr. David Tom Cooke @DavidCookeMD I'm a bot. Sorry. #LCSM |
| Sarika Jain @drjainsp @TimAllenMDJD We can do conventional Sanger sequencing where you can sequencing one portion of the DNA (gene) at one time. Next-Generation Sequencing does massively parallel sequencing of multiple genes. We can also sequence the whole genome.#LCSM |
| #LCSM Chat @lcsmchat RT @jfowlerpharmd: @TimAllenMDJD Can you elaborate on when/why “IO testing” is done (PD-L1, TMB, T-cell inflamed GEP) & how it differs from EGFR/ALK/etc? Are these all from same tissue sample and done at same time? #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Exactly. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A4: A4: Here are the revised lung cancer biomarker guidelines. https://t.co/8NFvL3rewb #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM Not all cases are straightforward. Sometimes immunostains dont work and we cant exactly classify tumor as adenocarcinoma or squamous cell carcinoma,or even large cell neuroendocrine Ca and in that case call it Nonsmall cell carcinoma (NSCLC) NOS https://t.co/AgxS2HXVxk |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: T4 Not necessarily immediately. However if done as a send out, often is added on to the original report as an addendum. #LCSM |
| Bob Steele @steele_bob RT @DevikaDasMD: @TimAllenMDJD @lcsmchat A4 This is where communication with the medical oncologist is essential. Limited number of molecular markers vs need to do large panel sequencing. Pathology is thus a critical member of the multidisciplinary team #lcsm |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @plh4lisa @TimAllenMDJD It will change when reliable biomarkers are found for squamous LC, and treatments are available. We have a ways to go yet. But some known adeno targets are also in squamous cell LC. #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM Not all cases are straightforward. Sometimes immunostains dont work and we cant exactly classify tumor as adenocarcinoma or squamous cell carcinoma,or even large cell neuroendocrine Ca and in that case call it Nonsmall cell carcinoma (NSCLC) NOS https://t.co/AgxS2HXVxk |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A4: A4: Here are the revised lung cancer biomarker guidelines. https://t.co/8NFvL3rewb #LCSM |
| KC Dill @kasedill @tilting As a patient, no thank you I would be concerned about errors.. I prefer highly trained pathologists #lcsm |
| #LCSM Chat @lcsmchat RT @drjainsp: @TimAllenMDJD We can do conventional Sanger sequencing where you can sequencing one portion of the DNA (gene) at one time. Next-Generation Sequencing does massively parallel sequencing of multiple genes. We can also sequence the whole genome.#LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD RT @TimAllenMDJD: A4: A4: Here are the revised lung cancer biomarker guidelines. https://t.co/8NFvL3rewb #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Beautiful images, @israhkhan #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: @plh4lisa @TimAllenMDJD It will change when reliable biomarkers are found for squamous LC, and treatments are available. We have a ways to go yet. But some known adeno targets are also in squamous cell LC. #LCSM |
| Jennifer Ersek @JLErsek @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
| Bob Steele @steele_bob RT @JackWestMD: A4: A4: so, largely based on the probability of finding result that would change management for that particular type of cancer, along w/the timing of getting results back. In reality, this is also shaped by how much tissue is available, at least if scarce & choices must be made #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DavidCookeMD: T4 Not necessarily immediately. However if done as a send out, often is added on to the original report as an addendum. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Last topic T5 is on the way … #LCSM |
| Betsy @MAmaskwearer So, by amplify you mean isolate and multiply and then analyze by sequencing it? #LCSM |
| Bob Steele @steele_bob RT @israhkhan: #LCSM Not all cases are straightforward. Sometimes immunostains dont work and we cant exactly classify tumor as adenocarcinoma or squamous cell carcinoma,or even large cell neuroendocrine Ca and in that case call it Nonsmall cell carcinoma (NSCLC) NOS https://t.co/AgxS2HXVxk |
| Dr. David Tom Cooke @DavidCookeMD A week+ #LCSM |
| #LCSM Chat @lcsmchat RT @JLErsek: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @drjainsp: @TimAllenMDJD We can do conventional Sanger sequencing where you can sequencing one portion of the DNA (gene) at one time. Next-Generation Sequencing does massively parallel sequencing of multiple genes. We can also sequence the whole genome.#LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Last topic T5 is on the way … #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: T4 Does the biomarker testing results become part of the original pathology report regardless of where testing is done? #LCSM |
| Bob Steele @steele_bob RT @JLErsek: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
| #LCSM Chat @lcsmchat RT @wildwestannie: So, by amplify you mean isolate and multiply and then analyze by sequencing it? #LCSM |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: A week+ #LCSM |
| Dianne Grunes @DrGrunes RT @JJBtweetin: @JackWestMD I think AI will be very helpful in the near future. But AI will never advocate for patients or contribute to multidisciplinary teams the way pathologists do. Just look at this thread! #LCSM |
 | Paula @lungcancer1964 #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We never have any fun here. #LCSM |
| Jennifer Ersek @JLErsek @TimAllenMDJD I’ll be checking this one out. Thanks!! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: I view AI in pathology and radiology, similar to robotics in surgery. These technologies will be adjunct tools used by the modern pathologist and radiologist. Not disruptive replacement. #HumansAreUnderrated #LCSM |
| Dr. David Tom Cooke @DavidCookeMD RT @TimAllenMDJD: A4: A4: Here are the revised lung cancer biomarker guidelines. https://t.co/8NFvL3rewb #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD T5: If you have talked to your pathologist, what did you learn? If you haven’t, what would you like to learn? #LCSM |
 | Alex C☮️🏳️🌈 🇺🇦 ✡️- #maskup #vaccinate @Bronx2216 RT @JJBtweetin: @JackWestMD I think AI will be very helpful in the near future. But AI will never advocate for patients or contribute to multidisciplinary teams the way pathologists do. Just look at this thread! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @JJBtweetin: @JackWestMD I think AI will be very helpful in the near future. But AI will never advocate for patients or contribute to multidisciplinary teams the way pathologists do. Just look at this thread! #LCSM |
| Sarika Jain @drjainsp @wildwestannie Exactly!#LCSM |
| #LCSM Chat @lcsmchat @lungcancer1964 We see you! #lcsm |
 | indriya @indriya201611 RT @israhkhan: #LCSM these are various faces of adenocarcinoma https://t.co/498NdyOQVd |
| Dr. David Tom Cooke @DavidCookeMD RT @JLErsek: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DevikaDasMD: @TimAllenMDJD @lcsmchat A4 This is where communication with the medical oncologist is essential. Limited number of molecular markers vs need to do large panel sequencing. Pathology is thus a critical member of the multidisciplinary team #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @DrGrunes: @JFreemanDaily @drjainsp @TimAllenMDJD It is what we look at when evaluating very small biopsies. We are looking at individual cells rather than the tissue #lcsm |
| Jill Feldman @jillfeldman4 T4 My concern is when biomarker testing is done elsewhere and the results aren't always interpreted correctly by the oncologist, which results in the patient getting the wrong treatment - happens too often! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD A5: We pathologists are here for you! Get your diagnostic report and read it! We’re happy to discuss it with you, and look at your case slides with you! #CallMeMaybe #PatientsFirst #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DavidCookeMD: A week+ #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T5: T5: If you have talked to your pathologist, what did you learn? If you haven’t, what would you like to learn? #LCSM |
| #LCSM Chat @lcsmchat RT @jillfeldman4: T4 My concern is when biomarker testing is done elsewhere and the results aren't always interpreted correctly by the oncologist, which results in the patient getting the wrong treatment - happens too often! #LCSM |
| Israh (Khan)Akhtar @israhkhan #LCSM Micropapillary adenocarcinoma, is a type of adenocarcinoma with poor prognosis https://t.co/11KpViB1jr |
| Lisa Moran @plh4lisa @TimAllenMDJD Is this truly standard across the board or suggested and hospitals make v their own choice? #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: A5: A5: We pathologists are here for you! Get your diagnostic report and read it! We’re happy to discuss it with you, and look at your case slides with you! #CallMeMaybe #PatientsFirst #LCSM |
| Bob Steele @steele_bob RT @jillfeldman4: T4 My concern is when biomarker testing is done elsewhere and the results aren't always interpreted correctly by the oncologist, which results in the patient getting the wrong treatment - happens too often! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: @DavidCookeMD What is the time difference for getting results? #LCSM |
| KC Dill @kasedill RT @JLErsek: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
 | Etan Marks, DO @et565 RT @DrMisialek: T3: T3: Pathologists train for years to recognize cancer cells, and never stop learning! Sometimes it can be very difficult to diagnose. #LCSM |
| Janet Freeman-Daily @JFreemanDaily @jillfeldman4 @DavidCookeMD You are asking all the right questions, Jill! #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM Micropapillary adenocarcinoma, is a type of adenocarcinoma with poor prognosis https://t.co/11KpViB1jr |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Pathologists should interpret them. Right, @drjainsp ? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM Micropapillary adenocarcinoma, is a type of adenocarcinoma with poor prognosis https://t.co/11KpViB1jr |
| #LCSM Chat @lcsmchat RT @plh4lisa: @TimAllenMDJD Is this truly standard across the board or suggested and hospitals make v their own choice? #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @jfowlerpharmd: @TimAllenMDJD Can you elaborate on when/why “IO testing” is done (PD-L1, TMB, T-cell inflamed GEP) & how it differs from EGFR/ALK/etc? Are these all from same tissue sample and done at same time? #lcsm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Pathologists should interpret them. Right, @drjainsp ? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: T4 Not necessarily immediately. However if done as a send out, often is added on to the original report as an addendum. #LCSM |
| Dr. David Tom Cooke @DavidCookeMD A5 I always accompany my own frozen section specimen to the pathology frozen section room in the OR and sit and "Shoot the breeze" with the pathologists and techs. #LCSM |
| Janet Freeman-Daily @JFreemanDaily I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Egad. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: @jillfeldman4 @DavidCookeMD You are asking all the right questions, Jill! #LCSM |
| Betsy @MAmaskwearer @israhkhan Ugly. Definitely worthy of killing! #lcsm |
| #LCSM Chat @lcsmchat RT @DavidCookeMD: A5 I always accompany my own frozen section specimen to the pathology frozen section room in the OR and sit and "Shoot the breeze" with the pathologists and techs. #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| Janet Freeman-Daily @JFreemanDaily RT @israhkhan: #LCSM Micropapillary adenocarcinoma, is a type of adenocarcinoma with poor prognosis https://t.co/11KpViB1jr |
| Dr. David Tom Cooke @DavidCookeMD RT @JFreemanDaily: I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: A5 I always accompany my own frozen section specimen to the pathology frozen section room in the OR and sit and "Shoot the breeze" with the pathologists and techs. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Pathologists should interpret them. Right, @drjainsp ? #LCSM |
| Bob Steele @steele_bob RT @JFreemanDaily: I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD It's this face to face communication that can sometimes make all the difference. Sometimes there are subtleties that are difficult to explain with a phone call to the surgeon in the operative suite I also like to go to the op suite and speak to the thoracic surgeon directly #LCSM |
| Janet Freeman-Daily @JFreemanDaily @plh4lisa @TimAllenMDJD We know for a fact that not all clinics/physicians adopt new guidelines as soon as they're published. It takes a while for standard of care to adjust to new guidelines, and LC guidelines are changing REALLY fast. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @wildwestannie: @israhkhan Ugly. Definitely worthy of killing! #lcsm |
| Jennifer Ersek @JLErsek @jillfeldman4 Many sources of info for oncologists—they don’t have to do it alone unless they choose to! Virtual molecular tumor boards open to many, some centers have internal boards, most of the NGS testing companies have support available to oncs for treatment decision making too! #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: It's this face to face communication that can sometimes make all the difference. Sometimes there are subtleties that are difficult to explain with a phone call to the surgeon in the operative suite I also like to go to the op suite and speak to the thoracic surgeon directly #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: A5: A5: We pathologists are here for you! Get your diagnostic report and read it! We’re happy to discuss it with you, and look at your case slides with you! #CallMeMaybe #PatientsFirst #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @plh4lisa @TimAllenMDJD We know for a fact that not all clinics/physicians adopt new guidelines as soon as they're published. It takes a while for standard of care to adjust to new guidelines, and LC guidelines are changing REALLY fast. #LCSM |
| Etan Marks, DO @et565 @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
| #LCSM Chat @lcsmchat RT @JLErsek: @jillfeldman4 Many sources of info for oncologists—they don’t have to do it alone unless they choose to! Virtual molecular tumor boards open to many, some centers have internal boards, most of the NGS testing companies have support available to oncs for treatment decision making too! #LCSM |
| Dr. David Tom Cooke @DavidCookeMD RT @TimAllenMDJD: It's this face to face communication that can sometimes make all the difference. Sometimes there are subtleties that are difficult to explain with a phone call to the surgeon in the operative suite I also like to go to the op suite and speak to the thoracic surgeon directly #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD #LCSM FTW #goteam |
| Israh (Khan)Akhtar @israhkhan #LCSM Many a times we pathologists are not lucky to have enough cells to do molecular testing. For example in this cell block we have only 24 tumor cells, which is not enough for any test. https://t.co/1b6FN45b9k |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD I eventually met the pathologist that runs the lab that did my biomarker testing. We had a GREAT conversation. She even knew where my slides were! #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat @drjainsp Agree with Jill. There is scarce outreach and education on interpreting on of NGS reports- education is key #lcsm |
| #LCSM Chat @lcsmchat RT @et565: @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Very dynamic. New information always coming. But we must keep pace! #LCSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #LCSM Many a times we pathologists are not lucky to have enough cells to do molecular testing. For example in this cell block we have only 24 tumor cells, which is not enough for any test. https://t.co/1b6FN45b9k |
| Janet Freeman-Daily @JFreemanDaily RT @JLErsek: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: @TimAllenMDJD Here is another *free* paper on updates in #NSCLC biomarker testing: https://t.co/Df7QP7h09k #LCSM |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @TimAllenMDJD I eventually met the pathologist that runs the lab that did my biomarker testing. We had a GREAT conversation. She even knew where my slides were! #LCSM |
| Betsy @MAmaskwearer RT @JFreemanDaily: @plh4lisa @TimAllenMDJD We know for a fact that not all clinics/physicians adopt new guidelines as soon as they're published. It takes a while for standard of care to adjust to new guidelines, and LC guidelines are changing REALLY fast. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @israhkhan: #LCSM Many a times we pathologists are not lucky to have enough cells to do molecular testing. For example in this cell block we have only 24 tumor cells, which is not enough for any test. https://t.co/1b6FN45b9k |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @TimAllenMDJD @lcsmchat @drjainsp Agree with Jill. There is scarce outreach and education on interpreting on of NGS reports- education is key #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @et565: @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
| Danielle Pardue @Actorielle RT @et565: @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
 | Steve Holderness @dark_hawk_98 @israhkhan @lcsmchat #LCSM why does Micropapillary Adenocarcinoma have a poor prognosis? |
| H. Jack West, MD @JackWestMD A5: As a med onc, IMO plenty of cases have some nuance that could be clinically relevant, such as very aggressive features or discussing the mix of squamous & adeno features, or to clarify the probability that a specific but rare mutation should alter treatment. #LCSM |
 | Lesli Lord @MDTweetThyself RT @JFreemanDaily: I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| #LCSM Chat @lcsmchat RT @dark_hawk_98: @israhkhan @lcsmchat #LCSM why does Micropapillary Adenocarcinoma have a poor prognosis? |
| Sarika Jain @drjainsp @TimAllenMDJD Yes. A molecular pathologist must always interpret the results as these are very complex. Also these results must be discussed in molecular tumor boards to make a treatment decision with molecular pathologist and oncologist on board.#LCSM |
| Lisa Moran @plh4lisa Ifeel like pathology happens in the background and I wouldn't have access to my pathologist to ask any questions. #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @israhkhan: #LCSM Many a times we pathologists are not lucky to have enough cells to do molecular testing. For example in this cell block we have only 24 tumor cells, which is not enough for any test. https://t.co/1b6FN45b9k |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Don't hesitate to call your pathologist or schedule a time to review your own case. We are the physicians that diagnose the patient's disease, and by doing so start them on their journey for treatment. And hopefully recovery! #PatientsFirst #LCSM |
| #LCSM Chat @lcsmchat RT @JackWestMD: A5: A5: As a med onc, IMO plenty of cases have some nuance that could be clinically relevant, such as very aggressive features or discussing the mix of squamous & adeno features, or to clarify the probability that a specific but rare mutation should alter treatment. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @et565: @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @drjainsp: @TimAllenMDJD Yes. A molecular pathologist must always interpret the results as these are very complex. Also these results must be discussed in molecular tumor boards to make a treatment decision with molecular pathologist and oncologist on board.#LCSM |
| #LCSM Chat @lcsmchat RT @drjainsp: @TimAllenMDJD Yes. A molecular pathologist must always interpret the results as these are very complex. Also these results must be discussed in molecular tumor boards to make a treatment decision with molecular pathologist and oncologist on board.#LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JackWestMD: A5: A5: As a med onc, IMO plenty of cases have some nuance that could be clinically relevant, such as very aggressive features or discussing the mix of squamous & adeno features, or to clarify the probability that a specific but rare mutation should alter treatment. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @JLErsek: @jillfeldman4 Many sources of info for oncologists—they don’t have to do it alone unless they choose to! Virtual molecular tumor boards open to many, some centers have internal boards, most of the NGS testing companies have support available to oncs for treatment decision making too! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: It's this face to face communication that can sometimes make all the difference. Sometimes there are subtleties that are difficult to explain with a phone call to the surgeon in the operative suite I also like to go to the op suite and speak to the thoracic surgeon directly #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD #LikeABoss #LCSM |
| Danielle Pardue @Actorielle RT @JLErsek: @jillfeldman4 Many sources of info for oncologists—they don’t have to do it alone unless they choose to! Virtual molecular tumor boards open to many, some centers have internal boards, most of the NGS testing companies have support available to oncs for treatment decision making too! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We’re in our final minutes - closing thoughts? #LCSM |
| KC Dill @kasedill @TimAllenMDJD T5 I learned from a fabulous pathologist that mine is adenosquamous and approx 4% of all NSCLC has this diagnosis. #LCSM |
| Justin Bateman @JJBtweetin @tilting @TimAllenMDJD I agree, I wish it was easier. So many pathologists I know would embrace the opportunity to meet one-on-one with patients. #lcsm |
| Danielle Pardue @Actorielle RT @JFreemanDaily: @plh4lisa @TimAllenMDJD We know for a fact that not all clinics/physicians adopt new guidelines as soon as they're published. It takes a while for standard of care to adjust to new guidelines, and LC guidelines are changing REALLY fast. #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Don't hesitate to call your pathologist or schedule a time to review your own case. We are the physicians that diagnose the patient's disease, and by doing so start them on their journey for treatment. And hopefully recovery! #PatientsFirst #LCSM |
 | Dennis Keim @denniskeim RT @israhkhan: #LCSM This is an example of Squamous cell carcinoma. In this immunotherapy is helpful (treatment by Keytruda). So if tumor cells are positive for PDL1 these patients generally are responsive to Keytruda. The immunostain here used is p40 (slide 3) https://t.co/SOGHt6AnN5 |
| Danielle Pardue @Actorielle RT @TimAllenMDJD: It's this face to face communication that can sometimes make all the difference. Sometimes there are subtleties that are difficult to explain with a phone call to the surgeon in the operative suite I also like to go to the op suite and speak to the thoracic surgeon directly #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We’re in our final minutes - closing thoughts? #LCSM |
| Bob Steele @steele_bob RT @JJBtweetin: @tilting @TimAllenMDJD I agree, I wish it was easier. So many pathologists I know would embrace the opportunity to meet one-on-one with patients. #lcsm |
| #LCSM Chat @lcsmchat RT @kasedill: @TimAllenMDJD T5 I learned from a fabulous pathologist that mine is adenosquamous and approx 4% of all NSCLC has this diagnosis. #LCSM |
| Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat @drjainsp TPS vs CPS scores for immunotherapy use - i have seen plenty of missed opportunities in second opinions #lcsm |
| #LCSM Chat @lcsmchat RT @JJBtweetin: @tilting @TimAllenMDJD I agree, I wish it was easier. So many pathologists I know would embrace the opportunity to meet one-on-one with patients. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD This is one of the best-ever #LCSM Chats! Lots of different stakeholders asking and answering questions. I LOVE it! Thanks for putting this chat together Tim! |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD We gotta change that narrative! #CallMeMaybe #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DevikaDasMD: @TimAllenMDJD @lcsmchat @drjainsp TPS vs CPS scores for immunotherapy use - i have seen plenty of missed opportunities in second opinions #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @JJBtweetin: @tilting @TimAllenMDJD I agree, I wish it was easier. So many pathologists I know would embrace the opportunity to meet one-on-one with patients. #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD I'm one! #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @kasedill: @TimAllenMDJD T5 I learned from a fabulous pathologist that mine is adenosquamous and approx 4% of all NSCLC has this diagnosis. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Don't hesitate to call your pathologist or schedule a time to review your own case. We are the physicians that diagnose the patient's disease, and by doing so start them on their journey for treatment. And hopefully recovery! #PatientsFirst #LCSM |
| Faces of Lung Cancer @LungCancerFaces Thank you @TimAllenMDJD for being our awesome moderator tonight. What a terrific debut. #LikeaBoss #lcsm |
 | Mary Jo Robinson @mjrobin6714 RT @JFreemanDaily: I love how oncologists and other docs are asking pathologists questions in the chat! This is what #LCSM chat is all about. |
| Janet Freeman-Daily @JFreemanDaily RT @JackWestMD: A5: A5: As a med onc, IMO plenty of cases have some nuance that could be clinically relevant, such as very aggressive features or discussing the mix of squamous & adeno features, or to clarify the probability that a specific but rare mutation should alter treatment. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thank ~you~ for your patience and great help, @JFreemanDaily #LCSM |
| Lisa Moran @plh4lisa @TimAllenMDJD Pathology is fascinating. Thank you for educating and enlightening us. #lcsm |
| Jennifer Ersek @JLErsek @plh4lisa It never hurts to ask! #LCSM |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @TimAllenMDJD @lcsmchat @drjainsp TPS vs CPS scores for immunotherapy use - i have seen plenty of missed opportunities in second opinions #lcsm |
| Devika Das, MD, MSHQS @DevikaDasMD @TimAllenMDJD @lcsmchat Education and outreach needs to keep up with the rate advance in sciences especially in pathology to prevent inequity in cancer care #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Very dynamic. New information always coming. But we must keep pace! #LCSM |
| Dr. David Tom Cooke @DavidCookeMD Great chat @TimAllenMDJD and @lcsmchat !! Also thanks to @IASLC for highlighting our chat on it's Breaking News page! https://t.co/zLhwogBhyt #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thank you all, #LCSM team. It has been a privilege to participate, and a great honor to moderate this #LCSM session. |
| Narjust Florez (Duma), M.D. @NarjustFlorezMD @TimAllenMDJD I have you in speed dial. Also, love tumor boards, we get to see you in action! #LCSM https://t.co/wgJnSa4V2M |
| Janet Freeman-Daily @JFreemanDaily RT @DevikaDasMD: @TimAllenMDJD @lcsmchat @drjainsp Agree with Jill. There is scarce outreach and education on interpreting on of NGS reports- education is key #lcsm |
| Jill Feldman @jillfeldman4 T5 I think pathologists are more behind the scenes than radiologists. I would love to meet and talk to my pathologist. Maybe I will ask next time :) #LCSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Thank ~you~ for your patience and great help, @JFreemanDaily #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Absolutely! #LCSM |
| H. Jack West, MD @JackWestMD Congrats & thanks for moderating such an energetic #LCSM chat, @TimAllenMDJD -- kudos! |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We gotta change that narrative! #CallMeMaybe #LCSM |
| #LCSM Chat @lcsmchat RT @DevikaDasMD: @TimAllenMDJD @lcsmchat Education and outreach needs to keep up with the rate advance in sciences especially in pathology to prevent inequity in cancer care #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thanks for providing me this extraordinary opportunity, @LungCancerFaces #LCSM |
| Janet Freeman-Daily @JFreemanDaily @dark_hawk_98 @israhkhan @lcsmchat .@TimAllenMDJD You picked it up quickly. Looking forward to your next moderating job! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @jillfeldman4: T5 I think pathologists are more behind the scenes than radiologists. I would love to meet and talk to my pathologist. Maybe I will ask next time :) #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Thank you all, #LCSM team. It has been a privilege to participate, and a great honor to moderate this #LCSM session. |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Thanks, Jack. Just tryin' to keep up with you! #LCSM |
| Jennifer Ersek @JLErsek @TimAllenMDJD I may take you up on that #callmemaybe policy myself! #LCSM |
| Bob Steele @steele_bob Great LCSM Chat session tonight. Thanks to all & hope to see you next month. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DevikaDasMD: @TimAllenMDJD @lcsmchat Education and outreach needs to keep up with the rate advance in sciences especially in pathology to prevent inequity in cancer care #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Do so! Pathologists are caring physicians who can explain to you your diagnosis. And show you what your up against. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @LungCancerFaces: Thank you @TimAllenMDJD for being our awesome moderator tonight. What a terrific debut. #LikeaBoss #lcsm |
 | الـفيزياء الطبيـة☢ @aleneziahmed1 RT @RadiologyACR: Using #CT with radiation doses as low as those from plain x-rays, researchers were able to catch sold lung nodules with 98.5 percent sensitivity and 100 percent specificity via @RadiologyBiz https://t.co/nlPO2QVSJZ #lcsm #lungcancer |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Do so! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: We gotta change that narrative! #CallMeMaybe #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD I'll be back. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: We’re in our final minutes - closing thoughts? #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @steele_bob: Great LCSM Chat session tonight. Thanks to all & hope to see you next month. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD Yes, shout out and many thanks to @IASLC #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @DevikaDasMD: @TimAllenMDJD @lcsmchat Education and outreach needs to keep up with the rate advance in sciences especially in pathology to prevent inequity in cancer care #lcsm |
 | Brad Zang @Bradzang RT @TimAllenMDJD: A4: A4: Most molecular biomarker testing is performed on lung adenocarcinomas rather than on squamous cell carcinomas or small cell carcinomas. That is because adenocarcinomas may respond to molecular therapies when the biomarker indicates. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD It has been my great pleasure. And I agree; every day is fascinating to me as a lung pathologist. No burnout here. #LCSM #PatientsFirst |
| Devika Das, MD, MSHQS @DevikaDasMD @NarjustDuma @JackWestMD @lcsmchat @cityofhope I wish some of ya’ll would decide to come to Alabama. We need more thoracic oncologists and no snow 😬#lcsm |
| KC Dill @kasedill @TimAllenMDJD I enjoy learning about all aspects of lc Thank you as always #lcsm. I look forward to chatting each month so much my kiddos know which night it is..#Lcsm |
| Steve Holderness @dark_hawk_98 @kasedill @TimAllenMDJD From now on your oncologist should consider you his living unicorn I tease my oncologist about that myself (being his unicorn) now that I am 6+ year survivor of Stage IIIA NSCLC Squamous. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @kasedill: @TimAllenMDJD I enjoy learning about all aspects of lc Thank you as always #lcsm. I look forward to chatting each month so much my kiddos know which night it is..#Lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Yes, shout out and many thanks to @IASLC #LCSM |
| Mary Jo Robinson @mjrobin6714 RT @et565: @TimAllenMDJD But seriously, molecular pathologists need to stay up to date with the current literature and know which tests will add value. Meaning, which tests will help with prognosis, diagnosis AND possible treatments. That is how a molecular pathologist adds value to the team. #lcsm |
| Dr. David Tom Cooke @DavidCookeMD Yes. All of oncology is emotionally stressful. Across all disciplines and stakeholders. But #LCSM is here to help! |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD #lcsm |
| Mary Jo Robinson @mjrobin6714 RT @israhkhan: #LCSM Many a times we pathologists are not lucky to have enough cells to do molecular testing. For example in this cell block we have only 24 tumor cells, which is not enough for any test. https://t.co/1b6FN45b9k |
| Janet Freeman-Daily @JFreemanDaily Transcript for the 03/07 #LCSM Chat "Biomarker Magicians (or, Why We Love Pathologists)" can be found here: https://t.co/Zsdn0A7mxc |
#LCSM content from Twitter.